The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | B | Blood and blood forming organs | |
| 2 | B05 | Blood substitutes and perfusion solutions | |
| 3 | B05A | Blood and related products | |
| 4 | B05AA | Blood substitutes and plasma protein fractions | |
| 5 | B05AA06 | Gelatin agents |
| Active Ingredient | Description | |
|---|---|---|
| Gelatin |
Gelatin is a colloidal plasma substitute. When used in the treatment of hypovolaemia gelatin produces significant increases in blood volume, cardiac output, stroke volume, blood pressure, urinary output and oxygen delivery. Gelatin promotes osmotic diuresis, thereby helping to protect the kidneys from the adverse effects of hypovolaemia. |
|
| Polygeline |
|
| Title | Information Source | Document Type | |
|---|---|---|---|
| VOLPLEX Solution for infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
